These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2329554)

  • 1. Nonpeptide angiotensin II receptor antagonists: N-[(benzyloxy)benzyl]imidazoles and related compounds as potent antihypertensives.
    Carini DJ; Duncia JV; Johnson AL; Chiu AT; Price WA; Wong PC; Timmermans PB
    J Med Chem; 1990 May; 33(5):1330-6. PubMed ID: 2329554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives.
    Duncia JV; Chiu AT; Carini DJ; Gregory GB; Johnson AL; Price WA; Wells GJ; Wong PC; Calabrese JC; Timmermans PB
    J Med Chem; 1990 May; 33(5):1312-29. PubMed ID: 2329553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives.
    Carini DJ; Duncia JV; Aldrich PE; Chiu AT; Johnson AL; Pierce ME; Price WA; Santella JB; Wells GJ; Wexler RR
    J Med Chem; 1991 Aug; 34(8):2525-47. PubMed ID: 1875348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies.
    Chiu AT; Duncia JV; McCall DE; Wong PC; Price WA; Thoolen MJ; Carini DJ; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1989 Sep; 250(3):867-74. PubMed ID: 2778716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]DUP 753, a highly potent and specific radioligand for the angiotensin II-1 receptor subtype.
    Chiu AT; McCall DE; Aldrich PE; Timmermans PB
    Biochem Biophys Res Commun; 1990 Nov; 172(3):1195-202. PubMed ID: 2244903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonpeptide angiotensin II receptor antagonists: a novel class of antihypertensive agents.
    Timmermans PB; Carini DJ; Chiu AT; Duncia JV; Price WA; Wells GJ; Wong PC; Wexler RR; Johnson AL
    Blood Vessels; 1990; 27(2-5):295-300. PubMed ID: 1978694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DuP 532: a second generation of nonpeptide angiotensin II receptor antagonists.
    Chiu AT; Carini DJ; Duncia JV; Leung KH; McCall DE; Price WA; Wong PC; Smith RD; Wexler RR; Timmermans PB
    Biochem Biophys Res Commun; 1991 May; 177(1):209-17. PubMed ID: 2043107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonpeptide angiotensin II receptor antagonists: synthesis, biological activities, and structure-activity relationships of imidazole-5-carboxylic acids bearing alkyl, alkenyl, and hydroxyalkyl substituents at the 4-position and their related compounds.
    Yanagisawa H; Amemiya Y; Kanazaki T; Shimoji Y; Fujimoto K; Kitahara Y; Sada T; Mizuno M; Ikeda M; Miyamoto S; Furukawa Y; Koike H
    J Med Chem; 1996 Jan; 39(1):323-38. PubMed ID: 8568823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New nonpeptide angiotensin II receptor antagonists. 2. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)quinoline derivatives.
    Bradbury RH; Allott CP; Dennis M; Fisher E; Major JS; Masek BB; Oldham AA; Pearce RJ; Rankine N; Revill JM
    J Med Chem; 1992 Oct; 35(22):4027-38. PubMed ID: 1433210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.
    Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Oct; 255(1):211-7. PubMed ID: 2213556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II receptor subtypes and their selective nonpeptide ligands.
    Chiu AT; McCall DE; Ardecky RJ; Duncia JV; Nguyen TT; Timmermans PB
    Receptor; 1990-1991 Winter; 1(1-2):33-40. PubMed ID: 2152371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of novel nonpeptide angiotensin II receptor antagonists: imidazo[4,5-c]pyridine derivatives with an aromatic substituent.
    Kiyama R; Fuji M; Hara M; Fujimoto M; Kawabata T; Nakamura M; Fujishita T
    Chem Pharm Bull (Tokyo); 1995 Mar; 43(3):450-60. PubMed ID: 7774028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new series of imidazolones: highly specific and potent nonpeptide AT1 angiotensin II receptor antagonists.
    Bernhart CA; Perreaut PM; Ferrari BP; Muneaux YA; Assens JL; Clément J; Haudricourt F; Muneaux CF; Taillades JE; Vignal MA
    J Med Chem; 1993 Oct; 36(22):3371-80. PubMed ID: 8230127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonpeptide angiotensin II receptor antagonists.
    Timmermans PB; Carini DJ; Chiu AT; Duncia JV; Price WA; Wells GJ; Wong PC; Wexler RR; Johnson AL
    Am J Hypertens; 1990 Aug; 3(8 Pt 1):599-604. PubMed ID: 2222950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for the chemical development of angiotensin II receptor antagonists.
    Wexler RR; Carini DJ; Duncia JV; Johnson AL; Wells GJ; Chiu AT; Wong PC; Timmermans PB
    Am J Hypertens; 1992 Dec; 5(12 Pt 2):209S-220S. PubMed ID: 1290616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional distribution of the two subtypes of angiotensin II receptor in rat brain using selective nonpeptide antagonists.
    Leung KH; Smith RD; Pieter ; Timmermans BM; Chiu AT
    Neurosci Lett; 1991 Feb; 123(1):95-8. PubMed ID: 2062460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydropyrimidine angiotensin II receptor antagonists.
    Atwal KS; Ahmed SZ; Bird JE; Delaney CL; Dickinson KE; Ferrara FN; Hedberg A; Miller AV; Moreland S; O'Reilly BC
    J Med Chem; 1992 Dec; 35(25):4751-63. PubMed ID: 1469703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
    Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-(carboxybenzyl)imidazole-5-acrylic acids: potent and selective angiotensin II receptor antagonists.
    Weinstock J; Keenan RM; Samanen J; Hempel J; Finkelstein JA; Franz RG; Gaitanopoulos DE; Girard GR; Gleason JG; Hill DT
    J Med Chem; 1991 Apr; 34(4):1514-7. PubMed ID: 2016730
    [No Abstract]   [Full Text] [Related]  

  • 20. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
    Wienen W; Mauz AB; Van Meel JC; Entzeroth M
    Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.